MARCAINE

This brand name is authorized in United States. It is also authorized in Canada, Israel, Lithuania, Netherlands, Poland, Romania, Singapore, Turkey.

Active ingredients

The drug MARCAINE contains one active pharmaceutical ingredient (API):

1	Bupivacaine UNII 7TQO7W3VT8 - BUPIVACAINE HYDROCHLORIDE
	Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.
	Read more about Bupivacaine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MARCAINE Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01BB01	Bupivacaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02241914, 02241917, 02305909, 02474247
IL	מִשְׂרַד הַבְּרִיאוּת	8366
LT	Valstybinė vaistų kontrolės tarnyba	1009148, 1009149, 1087894
NL	Z-Index G-Standaard	12560022, 12560030, 13611860
NL	Z-Index G-Standaard, PRK	1775, 39349, 6122
PL	Rejestru Produktów Leczniczych	100040918
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64893001, W64894001
SG	Health Sciences Authority	05679P, 05681P, 13211P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699874080519, 8699874080526
US	FDA, National Drug Code	0362-0557, 0409-1559, 0409-1560, 0409-1582, 0409-1587, 0409-1610, 0409-1761, 52584-559, 52584-560